Importance of Heart Rate During Exercise for Response to Cardiac Resynchronization Therapy
暂无分享,去创建一个
[1] David Tepper,et al. Optimal Left Ventricular Lead Position Predicts Reverse Remodeling and Survival After Cardiac Resynchronization Therapy , 2009 .
[2] C. Schneider,et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. , 2008, European heart journal.
[3] I. V. Van Gelder,et al. Impact of interventricular lead distance and the decrease in septal-to-lateral delay on response to cardiac resynchronization therapy. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[4] D. Atar,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 ‡ , 2008, European journal of heart failure.
[5] I. V. Van Gelder,et al. Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[6] Nick Freemantle,et al. Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial. , 2007, European heart journal.
[7] J. E. Hansen,et al. Effect of biventricular pacing on the exercise pathophysiology of heart failure. , 2007, Chest.
[8] J. Ottervanger,et al. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. , 2007, The American journal of cardiology.
[9] Jeroen J. Bax,et al. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. , 2006, European heart journal.
[10] J. Steinberg. Clinical ResearchHeart Rhythm Disorder: Editorial CommentDesperately Seeking a Randomized Clinical Trial of Resynchronization Therapy for Patients With Heart Failure and Atrial Fibrillation⁎ , 2006 .
[11] A. Auricchio,et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. , 2006, Journal of the American College of Cardiology.
[12] Jeroen J. Bax,et al. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy. , 2006, The American journal of cardiology.
[13] Jeroen J. Bax,et al. Cardiac resynchronization therapy: Part 1--issues before device implantation. , 2005, Journal of the American College of Cardiology.
[14] Hung-Fat Tse,et al. The incremental benefit of rate-adaptive pacing on exercise performance during cardiac resynchronization therapy. , 2005, Journal of the American College of Cardiology.
[15] Christophe Leclercq,et al. Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questions. , 2005, Journal of the American College of Cardiology.
[16] Jeroen J. Bax,et al. Left Ventricular Reverse Remodeling but Not Clinical Improvement Predicts Long-Term Survival After Cardiac Resynchronization Therapy , 2005, Circulation.
[17] M. Pfisterer,et al. Right atrial pacing impairs cardiac function during resynchronization therapy: acute effects of DDD pacing compared to VDD pacing. , 2005, Journal of the American College of Cardiology.
[18] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.
[19] Jeroen J. Bax,et al. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. , 2004, The American journal of cardiology.
[20] D. DeMets,et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.
[21] Jeroen J. Bax,et al. Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. , 2003, The American journal of cardiology.
[22] E. Foster,et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. , 2003, Journal of the American College of Cardiology.
[23] R. Canby,et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. , 2003, JAMA.
[24] S. Goodman,et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. , 2003, JAMA.
[25] Milton Packer,et al. Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.
[26] Stefan Sack,et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. , 2002, Journal of the American College of Cardiology.
[27] D. Delurgio,et al. Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.
[28] A. Auricchio,et al. Exercise performance following cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. , 2002, The American journal of cardiology.
[29] J. Daubert,et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. , 2001, The New England journal of medicine.